Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

571 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant therapy in melanoma.
Mohr P, Weichenthal M, Hauschild A. Mohr P, et al. Onkologie. 2003 Jun;26(3):227-33. doi: 10.1159/000071617. Onkologie. 2003. PMID: 12845206 Review.
Fotemustine and interferon alpha2b in metastatic malignant melanoma.
Weichenthal M, Mohr P, Stephan U, Altenhoff J, Kowalzick L, Marseille A, Sarkany M, Hossfeld DK, Breitbart EW. Weichenthal M, et al. Among authors: mohr p. J Cancer Res Clin Oncol. 1998 Jan;124(1):55-9. doi: 10.1007/s004320050134. J Cancer Res Clin Oncol. 1998. PMID: 9498836 Clinical Trial.
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
Hauschild A, Garbe C, Stolz W, Ellwanger U, Seiter S, Dummer R, Ugurel S, Sebastian G, Nashan D, Linse R, Achtelik W, Mohr P, Kaufmann R, Fey M, Ulrich J, Tilgen W. Hauschild A, et al. Among authors: mohr p. Br J Cancer. 2001 Apr 20;84(8):1036-42. doi: 10.1054/bjoc.2001.1731. Br J Cancer. 2001. PMID: 11308250 Free PMC article. Clinical Trial.
A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma.
Mornex F, Thomas L, Mohr P, Hauschild A, Delaunay MM, Lesimple T, Tilgen W, Bui BN, Guillot B, Ulrich J, Bourdin S, Mousseau M, Cupissol D, Bonneterre ME, De Gislain C, Bensadoun RJ, Clavel M. Mornex F, et al. Among authors: mohr p. Melanoma Res. 2003 Feb;13(1):97-103. doi: 10.1097/00008390-200302000-00016. Melanoma Res. 2003. PMID: 12569292 Clinical Trial.
[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma].
Mornex F, Thomas L, Mohr P, Hauschild A, Delaunay MM, Lesimple T, Tilgen W, Nguyen BB, Guillot B, Ulrich J, Bourdin S, Mousseau M, Cupissol D, Bonneterre J, de Gislain C, Bensadoun JR, Clavel M. Mornex F, et al. Among authors: mohr p. Cancer Radiother. 2003 Feb;7(1):1-8. doi: 10.1016/s1278-3218(02)00284-6. Cancer Radiother. 2003. PMID: 12648711 Clinical Trial. French.
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
Avril MF, Aamdal S, Grob JJ, Hauschild A, Mohr P, Bonerandi JJ, Weichenthal M, Neuber K, Bieber T, Gilde K, Guillem Porta V, Fra J, Bonneterre J, Saïag P, Kamanabrou D, Pehamberger H, Sufliarsky J, Gonzalez Larriba JL, Scherrer A, Menu Y. Avril MF, et al. Among authors: mohr p. J Clin Oncol. 2004 Mar 15;22(6):1118-25. doi: 10.1200/JCO.2004.04.165. J Clin Oncol. 2004. PMID: 15020614 Clinical Trial.
Low-frequency ultrasound treatment of chronic venous ulcers.
Weichenthal M, Mohr P, Stegmann W, Breitbart EW. Weichenthal M, et al. Among authors: mohr p. Wound Repair Regen. 1997 Jan-Mar;5(1):18-22. doi: 10.1046/j.1524-475X.1997.50107.x. Wound Repair Regen. 1997. PMID: 16984453
571 results